Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3466658 | 1.00 | KDM4E (0.49) | KDM4ENLRP3MEN1KMT2AGAA | |
| SCHEMBL3466659 | 1.00 | KDM4E (0.49) | KDM4ENLRP3MEN1KMT2AGAA | |
| SCHEMBL30776762 | 1.00 | KDM4E (0.49) | KDM4ENLRP3MEN1KMT2AGAA | |
| SCHEMBL11227410 | 0.90 | MEN1 (0.44) | KDM4ENLRP3MEN1KMT2AGAA | |
| SCHEMBL6882581 | 0.87 | KDM4E (0.45) | KDM4EATMALDH1A1TDP1CYP2D6 | |
| SCHEMBL8012133 | 0.87 | KDM4E (0.45) | KDM4EATMALDH1A1TDP1CYP2D6 | |
| SCHEMBL4975113 | 0.87 | KDM4E (0.45) | KDM4EATMALDH1A1TDP1CYP2D6 | |
| SCHEMBL11434002 | 0.86 | NLRP3 (0.45) | KDM4ENLRP3MEN1KMT2APTGS2 | |
| SCHEMBL15423242 | 0.83 | PTGS2 (0.44) | KDM4ENLRP3MEN1KMT2AGAA | |
| SCHEMBL16998575 | 0.83 | PTGS2 (0.44) | KDM4ENLRP3MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2892877-B1 | PROCESS FOR THE PREPARATION OF (S)-2-ETHYL-N-(1-METHOXYPROPAN -2-YL)-6-METHYL ANILINE | COUNCIL SCIENT IND RES (IN) | 2017-06-21 | — | — | EP | disclosed |
| US-9199930-B2 | Process for the preparation of (S)-2-ethyl-N-(1-methoxypropan-2-yl)-6-methyl aniline | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | disclosed |
| US-9199930-B2 | Process for the preparation of (S)-2-ethyl-N-(1-methoxypropan-2-yl)-6-methyl aniline | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-12-01 | — | — | US | disclosed |
| US-20150225340-A1 | PROCESS FOR THE PREPARATION OF (S)-2-ETHYL-N-(1-METHOXYPROPAN -2-YL)-6-METHYL ANILINE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-08-13 | — | — | US | disclosed |
| US-20150225340-A1 | PROCESS FOR THE PREPARATION OF (S)-2-ETHYL-N-(1-METHOXYPROPAN -2-YL)-6-METHYL ANILINE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-08-13 | — | — | US | disclosed |
| WO-2014037962-A1 | PROCESS FOR THE PREPARATION OF (S)-2-ETHYL-N-(1-METHOXYPROPAN -2-YL)-6-METHYL ANILINE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2014-03-13 | — | — | WO | disclosed |
| EP-2041150-B1 | DIPHOSPHINE LIGANDS | SOLVIAS AG (CH) | 2011-10-26 | — | — | EP | disclosed |
| US-20110054217-A1 | HYDROGENATION OF IMINES | UNITED PHOSPHORUS LIMITED (IN) | 2011-03-03 | — | — | US | disclosed |
| US-20110054217-A1 | HYDROGENATION OF IMINES | UNITED PHOSPHORUS LIMITED (IN) | 2011-03-03 | — | — | US | disclosed |
| WO-2009136409-A2 | HYDROGENATION OF IMINES | UNITED PHOSPHORUS LIMITED (IN) | 2009-11-12 | — | — | WO | disclosed |
| WO-2008000815-A1 | DIPHOSPHINE LIGANDS | SOLVIAS AG (CH) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007135179-A1 | CHIRAL LIGANDS USED IN TRANSITION METAL CATALYSTS FOR ASYMMETRIC ADDITION REACTIONS ESPECIALLY HYDROGENATION | SOLVIAS AG (CH) | 2007-11-29 | — | — | WO | disclosed |
| WO-2006003194-A1 | PROCESS FOR PREPARING AMINES AND A CARBOXAMIDE THEREOF | SOLVIAS AG (CH) | 2006-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225340-A1 | PROCESS FOR THE PREPARATION OF (S)-2-ETHYL-N-(1-METHOXYPROPAN -2-YL)-6-METHYL ANILINE | AZI2, HTR2A, HTR1B | KDM4E 205/4885NLRP3 3111/4885MEN1 1088/4885 |
| US-20110054217-A1 | HYDROGENATION OF IMINES | KMO, HPD, HRH3 | KDM4E 779/4885NLRP3 4164/4885MEN1 1170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.